176 related articles for article (PubMed ID: 15794857)
21. Immunohistochemical phenotyping of plasma cells in lymphoplasmacytic lymphoma/Waldenström's macroglobulinemia is comparable to flow cytometric techniques.
Howard MT; Hodnefield J; Morice WG
Clin Lymphoma Myeloma Leuk; 2011 Feb; 11(1):96-8. PubMed ID: 21454202
[TBL] [Abstract][Full Text] [Related]
22. IgM myeloma: case report with immunophenotypic profile.
Haghighi B; Yanagihara R; Cornbleet PJ
Am J Hematol; 1998 Dec; 59(4):302-8. PubMed ID: 9840911
[TBL] [Abstract][Full Text] [Related]
23. CD20-directed antibody-mediated immunotherapy induces responses and facilitates hematologic recovery in patients with Waldenstrom's macroglobulinemia.
Treon SP; Agus TB; Link B; Rodrigues G; Molina A; Lacy MQ; Fisher DC; Emmanouilides C; Richards AI; Clark B; Lucas MS; Schlossman R; Schenkein D; Lin B; Kimby E; Anderson KC; Byrd JC
J Immunother; 2001; 24(3):272-9. PubMed ID: 11394506
[TBL] [Abstract][Full Text] [Related]
24. Utility of flow cytometry in subtyping composite and sequential lymphoma.
Siebert JD; Mulvaney DA; Vukov AM; Knost JA; King DE; Craig FE
J Clin Lab Anal; 1999; 13(5):199-204. PubMed ID: 10494126
[TBL] [Abstract][Full Text] [Related]
25. Induction of isotype switching and Ig production by CD5+ and CD10+ human fetal B cells.
Punnonen J; Aversa GG; Vandekerckhove B; Roncarolo MG; de Vries JE
J Immunol; 1992 Jun; 148(11):3398-404. PubMed ID: 1375243
[TBL] [Abstract][Full Text] [Related]
26. [Complete response achieved after rituximab plus CHOP therapy in a patient with rapidly progressing Waldenstrom's macroglobulinemia].
Ise M; Sakai C; Kumagai K
Rinsho Ketsueki; 2009 Jan; 50(1):34-8. PubMed ID: 19225227
[TBL] [Abstract][Full Text] [Related]
27. Waldenström macroglobulinemia: a review of the entity and its differential diagnosis.
Shaheen SP; Talwalkar SS; Lin P; Medeiros LJ
Adv Anat Pathol; 2012 Jan; 19(1):11-27. PubMed ID: 22156831
[TBL] [Abstract][Full Text] [Related]
28. Gastric MALT lymphoma presenting as Waldenström's macroglobulinemia without bone marrow involvement.
Salle V; Smail A; Joly JP; Capiod JC; Gontier MF; Duhaut P; Ducroix JP
Clin Lymphoma Myeloma; 2007 Jul; 7(7):470-1. PubMed ID: 17875236
[TBL] [Abstract][Full Text] [Related]
29. The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease.
DiRaimondo F; Albitar M; Huh Y; O'Brien S; Montillo M; Tedeschi A; Kantarjian H; Lerner S; Giustolisi R; Keating M
Cancer; 2002 Mar; 94(6):1721-30. PubMed ID: 11920534
[TBL] [Abstract][Full Text] [Related]
30. An unusual case of leukemic mantle cell lymphoma with a blastoid component showing loss of CD5 and aberrant expression of CD10.
Morice WG; Hodnefield JM; Kurtin PJ; Hanson CA
Am J Clin Pathol; 2004 Jul; 122(1):122-7. PubMed ID: 15272540
[TBL] [Abstract][Full Text] [Related]
31. The Wayne State University Waldenstrom's Macroglobulinemia preclinical model for Waldenstrom's macroglobulinemia.
Al-Katib AM; Mensah-Osman E; Aboukameel A; Mohammad R
Semin Oncol; 2003 Apr; 30(2):313-7. PubMed ID: 12720160
[TBL] [Abstract][Full Text] [Related]
32. Prolymphocytoid transformation of follicular lymphoma with coexpression of CD5 and CD10.
Lau SK; Weiss LM; Zhang Y; Huang Q
Leuk Lymphoma; 2006 Mar; 47(3):541-7. PubMed ID: 16396778
[TBL] [Abstract][Full Text] [Related]
33. Differential diagnosis of Waldenstrom's macroglobulinemia from other low-grade B-cell lymphoproliferative disorders.
Pangalis GA; Kyrtsonis MC; Kontopidou FN; Vassilakopoulos TP; Siakantaris MP; Dimopoulou MN; Kittas C; Angelopoulou MK
Semin Oncol; 2003 Apr; 30(2):201-5. PubMed ID: 12720136
[TBL] [Abstract][Full Text] [Related]
34. B-chronic lymphocytic leukemia, small lymphocytic lymphoma, and lymphoplasmacytic lymphoma, including Waldenström's macroglobulinemia: a clinical, morphologic, and biologic spectrum of similar disorders.
Pangalis GA; Angelopoulou MK; Vassilakopoulos TP; Siakantaris MP; Kittas C
Semin Hematol; 1999 Apr; 36(2):104-14. PubMed ID: 10319379
[TBL] [Abstract][Full Text] [Related]
35. Waldenstrom macroglobulinemia with CD5+ expression presented as cryoglobulinemic glomerulonephropathy: a case report.
Kim YL; Gong SJ; Hwang YH; Joo JE; Cho YU; Lee JA; Sung SA; Lee SY; Kim NY
J Korean Med Sci; 2011 Jun; 26(6):824-8. PubMed ID: 21655071
[TBL] [Abstract][Full Text] [Related]
36. [Lymphoplasmacytic lymphoma: a clinicopathological and prognostic analysis of 27 cases].
Chen Y; Zhang F; Wu HM; Luo XL; Zhang KP; Liu YH
Zhonghua Bing Li Xue Za Zhi; 2021 Dec; 50(12):1346-1352. PubMed ID: 34865422
[No Abstract] [Full Text] [Related]
37. Gene Expression Profiling Reveals Aberrant T-cell Marker Expression on Tumor Cells of Waldenström's Macroglobulinemia.
Hao M; Barlogie B; Tricot G; Liu L; Qiu L; Shaughnessy JD; Zhan F
Clin Cancer Res; 2019 Jan; 25(1):201-209. PubMed ID: 30279229
[TBL] [Abstract][Full Text] [Related]
38. Lymphoplasmacytic lymphoma with IgA paraproteinemia mimicking Waldenstrom's Macroglobulinemia.
Basu D; Pathak D; Shyambabu C; Koner BC; Swaminathan RP
Indian J Pathol Microbiol; 2004 Oct; 47(4):515-7. PubMed ID: 16295380
[TBL] [Abstract][Full Text] [Related]
39. CXC chemokine ligand 13 and CC chemokine ligand 19 cooperatively render resistance to apoptosis in B cell lineage acute and chronic lymphocytic leukemia CD23+CD5+ B cells.
Chunsong H; Yuling H; Li W; Jie X; Gang Z; Qiuping Z; Qingping G; Kejian Z; Li Q; Chang AE; Youxin J; Jinquan T
J Immunol; 2006 Nov; 177(10):6713-22. PubMed ID: 17082584
[TBL] [Abstract][Full Text] [Related]
40. Persistent monotypic plasma cells with absence of neoplastic B cell component in a treated case of waldenström macroglobulinemia: a sign of residual disease?
Gajendra S; Sachdev R; Jha B; Goel S; Sahni T
J Clin Diagn Res; 2014 Nov; 8(11):FD12-3. PubMed ID: 25584235
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]